New insights in drug-induced mitochondrial toxicity.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current pharmaceutical design

• Publication date

  2011-06-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/138161211796904795PMID 21718246
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced Cardiomyocyte Ca2+ Cycling Precedes Terminal AV-Block in Mitochondrial Cardiomyopathy Mterf3 KO Mice

  2011cited by this paper
• Metabolic profiles show specific mitochondrial toxicities in vitro in myotube cells

  2011cited by this paper
• MUTANT HUNTINGTIN BINDS THE MITOCHONDRIAL FISSION GTPASE DRP1 AND INCREASES ITS ENZYMATIC ACTIVTY

  2011cited by this paper
• Mitochondrial DNA (mtDNA) and schizophrenia

  2011cited by this paper
• T16189C mitochondrial DNA variant is associated with metabolic syndrome in Caucasian subjects.

  2011cited by this paper
• Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease.

  2011cited by this paper
• Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia.

  2011cited by this paper
• Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.

  2011cited by this paper
• The GRACILE mutation introduced into Bcs1l causes postnatal complex III deficiency: A viable mouse model for mitochondrial hepatopathy

  2011cited by this paper
• Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients.

  2011cited by this paper
• Frequency and spectrum of mitochondrial 12S rRNA variants in 440 Han Chinese hearing impaired pediatric subjects from two otology clinics

  2011cited by this paper
• The rise and fall of rosiglitazone.

  2010cited by this paper
• Mitochondrial pharmacogenomics: barcode for antibiotic therapy.

  2010cited by this paper
• Mitochondria in cell death.

  2010cited by this paper
• Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication

  2010cited by this paper
• PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1

  2010cited by this paper
• Abnormal mitochondrial dynamics and neurodegenerative diseases.

  2010cited by this paper
• Mitochondrial DNA mutations and human disease.

  2010cited by this paper
• Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease.

  2010cited by this paper
• The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations

  2010cited by this paper
• Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss.

  2010cited by this paper
• Somatic mitochondrial DNA mutations in mammalian aging.

  2010cited by this paper
• Trovafloxacin, a fluoroquinolone antibiotic with hepatotoxic potential, causes mitochondrial peroxynitrite stress in a mouse model of underlying mitochondrial dysfunction.

  2010cited by this paper
• Mitochondrial shape changes: orchestrating cell pathophysiology

  2010cited by this paper
• High-Content Screening for Compounds That Affect mtDNA-Encoded Protein Levels in Eukaryotic Cells

  2010cited by this paper
• Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation

  2010cited by this paper
• Investigation of mitochondrial sequence variants associated with aminoglycoside-induced ototoxicity in South African TB patients on aminoglycosides.

  2010cited by this paper
• A high-throughput respirometric assay for mitochondrial biogenesis and toxicity.

  2010cited by this paper
• Mitochondrial and nuclear gene mutations in the type 2 diabetes patients of Coimbatore population

  2010cited by this paper
• Rethinking Alzheimer's Disease Therapy: Are Mitochondria the Key?

  2010cited by this paper
• Structure-based design of a thiazolidinedione which targets the mitochondrial protein mitoNEET.

  2010cited by this paper
• Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases

  2009cited by this paper
• Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes.

  2009cited by this paper
• Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.

  2009cited by this paper
• Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans.

  2009cited by this paper
• A prospective comparative study of gentamicin‐ and amikacin‐induced nephrotoxicity in patients with normal baseline renal function

  2009cited by this paper
• The role of mitochondrial network dynamics in the pathogenesis of Charcot-Marie-Tooth disease.

  2009cited by this paper
• Lateral-flow immunoassay for detecting drug-induced inhibition of mitochondrial DNA replication and mtDNA-encoded protein synthesis.

  2009cited by this paper
• Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice.

  2009cited by this paper
• Mouse models of oxidative phosphorylation defects: powerful tools to study the pathobiology of mitochondrial diseases.

  2009cited by this paper
• Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity.

  2009cited by this paper
• Neurological phenotype and reduced lifespan in heterozygous Tim23 knockout mice, the first mouse model of defective mitochondrial import.

  2009cited by this paper
• In vitro analysis of cell metabolism using a long-decay pH-sensitive lanthanide probe and extracellular acidification assay.

  2009cited by this paper
• Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder

  2009cited by this paper
• Ciglitazone induces apoptosis via activation of p38 MAPK and AIF nuclear translocation mediated by reactive oxygen species and Ca(2+) in opossum kidney cells.

  2009cited by this paper
• Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury

  2009cited by this paper
• Nuclear receptors and other nuclear transcription factors in mitochondria: regulatory molecules in a new environment.

  2008cited by this paper
• Cytochrome c: functions beyond respiration

  2008cited by this paper
• A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians

  2008cited by this paper
• Mitochondrial off targets of drug therapy.

  2008cited by this paper
• In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone.

  2008cited by this paper
• Impairing the Mitochondrial Fission and Fusion Balance: A New Mechanism of Neurodegeneration

  2008cited by this paper
• Mitochondrial Oxidative Phosphorylation Protein Levels in Peripheral Blood Mononuclear Cells Correlate with Levels in Subcutaneous Adipose Tissue within Samples Differing by HIV and Lipoatrophy Status

  2008cited by this paper
• Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro.

  2008cited by this paper
• Caspase-independent cell death: leaving the set without the final cut

  2008cited by this paper
• A mitochondrial protein compendium elucidates complex I disease biology.

  2008cited by this paper
• Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity

  2008cited by this paper
• MtDNA mutations, functional decline and turnover of mitochondria in aging.

  2008cited by this paper
• Amiodarone hepatotoxicity.

  2008cited by this paper
• Mitochondrial fission and fusion dynamics: the long and short of it

  2008cited by this paper
• Mitochondrial nuclear receptors and transcription factors: Who's minding the cell?

  2008cited by this paper
• Drug‐induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies

  2008cited by this paper
• Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats

  2008cited by this paper
• Associations between polymorphisms in the mitochondrial uncoupling proteins (UCPs) with T2DM.

  2008cited by this paper
• Advances in measuring cellular bioenergetics using extracellular flux.

  2008cited by this paper
• Reduced mitochondrial SOD displays mortality characteristics reminiscent of natural aging.

  2007cited by this paper
• MTERF3 is a negative regulator of mammalian mtDNA transcription.

  2007cited by this paper
• Tamoxifen-induced non-alcoholic steatohepatitis: where are we now and where are we going?

  2007cited by this paper
• Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities.

  2007cited by this paper
• Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells.

  2007cited by this paper
• Antimicrobial agents targeting the ribosome: the issue of selectivity and toxicity — lessons to be learned

  2007cited by this paper
• Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants.

  2007cited by this paper
• MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity

  2007cited by this paper
• Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria.

  2007cited by this paper
• Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration.

  2007cited by this paper
• The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity.

  2007cited by this paper
• Strategies to reduce late-stage drug attrition due to mitochondrial toxicity

  2007cited by this paper
• Ototoxicity.

  2007cited by this paper
• Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays.

  2007cited by this paper
• The significance of mitochondrial toxicity testing in drug development.

  2007cited by this paper
• Analysis of mitochondrial function using phosphorescent oxygen-sensitive probes

  2007cited by this paper
• Mitochondrial topoisomerases and alternative splicing of the human TOP1mt gene.

  2007cited by this paper
• Association between tetracycline or doxycycline and hepatotoxicity: a population based case–control study 1

  2007cited by this paper
• The European‐Specific Mitochondrial Cluster J/T Could Confer an Increased Risk of Insulin‐Resistance and Type 2 Diabetes: An Analysis of the m.4216T > C and m.4917A > G Variants

  2006cited by this paper
• Inhibition of Mammalian Mitochondrial Protein Synthesis by Oxazolidinones

  2006cited by this paper
• Toxicity of statins on rat skeletal muscle mitochondria

  2006cited by this paper
• Bioenergetics and the formation of mitochondrial reactive oxygen species.

  2006cited by this paper
• Quantitative Proteomic Comparison of Rat Mitochondria from Muscle, Heart, and Liver *S

  2006cited by this paper
• Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder.

  2006cited by this paper
• Physiological diversity of mitochondrial oxidative phosphorylation.

  2006cited by this paper
• Investigation of drug-induced mitochondrial toxicity using fluorescence-based oxygen-sensitive probes.

  2006cited by this paper
• Statins induce calcium-dependent mitochondrial permeability transition.

  2006cited by this paper
• The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase.

  2006cited by this paper
• Nimesulide-induced hepatic mitochondrial injury in heterozygous Sod2(+/-) mice.

  2006cited by this paper
• PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.

  2005cited by this paper
• Ciglitazone-Induced Lenticular Opacities in Rats: In Vivo and Whole Lens Explant Culture Evaluation

  2005cited by this paper
• Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid

  2005cited by this paper
• Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.

  2005cited by this paper
• Mitochondrial 12S rRNA mutations associated with aminoglycoside ototoxicity.

  2005cited by this paper
• Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia.

  2005cited by this paper

• Overview of neuroimaging in primary mitochondrial disorders

  2025cites this paper
• IMPAIRMENT OF PLATELET MITOCHONDRIAL RESPIRATION: AN OVERVIEW OF ANIMAL MODELS OF DISEASE AND DRUG-INDUCED TOXICITY

  2025cites this paper
• Trivalent and Pentavalent Antimonials Impair Cardiac Mitochondrial Function in Mice

  2025cites this paper
• Database screening as a strategy to identify endogenous candidate metabolites to probe and assess mitochondrial drug toxicity

  2023cites this paper
• Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation

  2022cites this paper
• Versatile Functional Energy Metabolism Platform Working From Research to Patient: An Integrated View of Cell Bioenergetics

  2022cites this paper
• Nonclinical Safety Signals in PharmaPendium Improve the Predictability of Human Drug-Induced Liver Injury.

  2022cites this paper
• Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury via mitochondrial or other mechanisms

  2021cites this paper
• Host Bioenergetic Parameters Reveal Cytotoxicity of Antituberculosis Drugs Undetected Using Conventional Viability Assays

  2021cites this paper
• Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests

  2021cites this paper
• Exploring Liver Mitochondrial Function by 13C-Stable Isotope Breath Tests: Implications in Clinical Biochemistry.

  2021cites this paper
• The mitochondrial paradox

  2020cites this paper
• Most Influential Physicochemical and In Vitro Assays Descriptors for Hepatotoxicity and Nephrotoxicity Prediction.

  2020cites this paper
• Identifying and Characterizing Stress Pathways of Concern for Consumer Safety in Next-Generation Risk Assessment

  2020cites this paper
• Linking Mitochondrial Dysfunction to Organismal and Population Health in the Context of Environmental Pollutants: Progress and Considerations for Mitochondrial Adverse Outcome Pathways

  2019cites this paper
• Environmental Toxicology and Chemistry

  2019cites this paper
• Mechanisms of chronic fialuridine hepatotoxicity as revealed in primary human hepatocyte spheroids.

  2019cites this paper
• MitoToxy assay: A novel cell-based method for the assessment of metabolic toxicity in a multiwell plate format using a lactate FRET nanosensor, Laconic

  2019cites this paper
• In Vitro Modulation of Redox and Metabolism Interplay at the Brain Vascular Endothelium: Genomic and Proteomic Profiles of Sulforaphane Activity

  2018cites this paper
• Mitochondrial dysfunction induced by leflunomide and its active metabolite.

  2018cites this paper
• Differentiated mitochondrial function in mouse 3T3 fibroblasts and human epithelial or endothelial cells in response to chemical exposure

  2018cites this paper
• POLG-related disorders and their neurological manifestations

  2018cites this paper
• Evaluation of in Vitro Mitochondrial Toxicity Assays and Physicochemical Properties for Prediction of Organ Toxicity Using 228 Pharmaceutical Drugs.

  2018cites this paper
• Drug-Induced Mitochondrial Toxicity

  2018cites this paper
• Combined Automated Measurement of Respiratory Chain Complexes and Oxidative Stress

  2018cites this paper
• Acylcarnitines as Translational Biomarkers of Mitochondrial Dysfunction

  2018cites this paper
• Detection of Mitochondrial Toxicity of Environmental Pollutants Using Caenorhabditis elegans

  2018cites this paper
• Mitochondrial Dysfunction in Drug‐Induced Liver Injury

  2018cites this paper
• Introduction: Mitochondria, the Cell Furnaces

  2018cites this paper
• MitoChip: A Transcriptomics Tool for Elucidation of Mechanisms of Mitochondrial Toxicity

  2018cites this paper
• Predicting Off‐Target Effects of Therapeutic Antiviral Ribonucleosides

  2018cites this paper
• Structure–Activity Modeling of Mitochondrial Dysfunction

  2018cites this paper
• EVALUATION OF ANTIOXIDANT EFFECTS OF MITOCHONDRIA- TARGETED POLYPHENOLIC AGENTS IN HUMAN SKIN FIBROBLASTS

  2018cites this paper
• Structure‐activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs

  2017cites this paper
• Human, Tissue-Engineered, Skeletal Muscle Myobundles to Measure Oxygen Uptake and Assess Mitochondrial Toxicity

  2017cites this paper
• Marine Genomics

  2017cites this paper
• De novo assembly and transcriptome characterization of the freshwater prawn Palaemonetes argentinus: Implications for a detoxification response.

  2017cites this paper
• The antibiotic chloramphenicol may be an effective new agent for inhibiting the growth of multiple myeloma

  2016cites this paper
• AMPK Activation Prevents and Reverses Drug-Induced Mitochondrial and Hepatocyte Injury by Promoting Mitochondrial Fusion and Function

  2016cites this paper
• Nonclinical Safety and Toxicology.

  2016cites this paper
• The contribution of drug-membrane biophysical studies for the development of safer NSAID: the case of diclofenac

  2015cites this paper
• Mitochondrial Dysfunction on the Toxic Effects of Anticancer Agents— From Lab Bench to Bedside

  2015cites this paper
• Circulating mitochondrial biomarkers for drug-induced liver injury.

  2015cites this paper
• Development of an in Silico Profiler for Mitochondrial Toxicity.

  2015cites this paper
• Computational toxicology

  2015cites this paper
• Xenobiotics that affect oxidative phosphorylation alter differentiation of human adipose-derived stem cells at concentrations that are found in human blood

  2015cites this paper
• Exploring liver mitochondrial function by ¹³C-stable isotope breath tests: implications in clinical biochemistry.

  2015cites this paper
• Conjugation with polyamines enhances the antibacterial and anticancer activity of chloramphenicol

  2014cites this paper
• Mitochondria: the gateway for tamoxifen-induced liver injury.

  2014cites this paper
• Tempol protects cardiomyocytes from nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.

  2014cites this paper
• The development of structure-activity relationships for mitochondrial dysfunction: uncoupling of oxidative phosphorylation.

  2013cites this paper
• Biological detection by optical oxygen sensing.

  2013cites this paper
• Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

  2013cites this paper
• Mitochondrial OXPHOS function is unaffected by chronic azithromycin treatment.

  2013cites this paper
• Breath tests with novel 13C-substrates for clinical studies of liver mitochondrial function in health and disease.

  2013cites this paper
• Treatment strategies for melanoma: pharmacological and toxicological action mechanisms of combined therapies

  2013influential citation
• Validation of a HTS-amenable assay to detect drug-induced mitochondrial toxicity in the absence and presence of cell death.

  2013cites this paper
• Interaction of nonsteroidal anti-inflammatory drugs with membranes: in vitro assessment and relevance for their biological actions.

  2013cites this paper
• Later-life Effects of Mitochondrial DNA Damage During Development in the Whole Organism Model Caenorhabditis elegans

  2012cites this paper
• Mitochondria and drugs.

  2012cites this paper
• In vitro salicylate does not further impair aging-induced brain mitochondrial dysfunction.

  2012cites this paper
• Toxicity evaluation of some traditional African spices on breast cancer cells and isolated rat hepatic mitochondria.

  2012cites this paper
• Investigative safety science as a competitive advantage for Pharma

  2012cites this paper
• Mitochondria as a pharmacological target: a clue for efficacy and a reason for toxicity.

  2011cites this paper